Schering Claritin DTC ads using FDA revised broadcast guidance airing.
This article was originally published in The Tan Sheet
Executive Summary
SCHERING CLARITIN ADS USING REVISED FDA BROADCAST GUIDANCE requirements broke Aug. 15 on primetime television. The "Blue Skies" TV "product and use" ad campaign for Schering-Plough's nonsedating prescription antihistamine Claritin (loratadine) 10 mg tablets is the second from a drug company employing the expanded parameters for direct-to-consumer broadcast advertising: Hoechst Marion Roussel began airing revised ads for its Allegra Rx antihistamine (fexofenadine) Aug. 11.
You may also be interested in...
DTC Advertising’s Blurred Line: Rx Spots Look A Lot Like OTC Promotions
Competition in the heartburn/GERD category between prescription and OTC drugs illustrates the increasing similarities between over-the-counter and Rx direct-to-consumer advertising
DTC Advertising’s Blurred Line: Rx Spots Look A Lot Like OTC Promotions
Competition in the heartburn/GERD category between prescription and OTC drugs illustrates the increasing similarities between over-the-counter and Rx direct-to-consumer advertising
DTC Advertising’s Blurred Line: Rx Spots Look A Lot Like OTC Promotions
Competition in the heartburn/GERD category between prescription and OTC drugs illustrates the increasing similarities between over-the-counter and Rx direct-to-consumer advertising